Fundz

Aardvark Therapeutics reported raising $85 Million in an initial SEC Form D filing, from an offering of $85 Million

PUBLIC · AARDMay 15, 2024

Amount Raised

$85 Million

$85 Million sold, per SEC Form D (first sale May 1, 2024)

Round Type

Venture

San DiegoManufacturingBiotechnology

Quick answer

Aardvark Therapeutics raised $85 Million in a funding round, dated May 1, 2024. Aardvark Therapeutics is based in San Diego, California, United States.

How much did Aardvark Therapeutics raise?
Aardvark Therapeutics raised $85 Million in a funding round on May 1, 2024.
What does Aardvark Therapeutics do?
Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation,..
Where is Aardvark Therapeutics based and how big is it?
Aardvark Therapeutics is based in San Diego, California, United States. Fundz records about 26 employees.
Who are the decision-makers at Aardvark Therapeutics?
Fundz holds 2 contacts at Aardvark Therapeutics, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Aardvark Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $226K on June 14, 2024.
  • Omniscient Neurotechnology raised $60M (Series C) on June 11, 2024.
  • Amend Surgical raised $1M on June 11, 2024.
  • DIH Holding US raised $3.3M (Seed) on June 7, 2024.
  • Advanced Medicine Partners raised $32M (Debt Financing) on June 6, 2024.
  • Scimplify raised $5M (Funding Round) on June 5, 2024.

Who to call at Aardvark Therapeutics, and when

A new round usually means Aardvark Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aardvark Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aardvark Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aardvark Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aardvark Therapeutics

Location

4370 La Jolla Village Drive

San Diego, California, United States

About

Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications. Aardvark's lead compound, oral ARD-101, is a potent bitter taste receptor (TAS2R) pan-agonist that stimulates enteroendocrine cells of the digestive tract to release multiple gut-peptide hormones including GLP-1 and the satiety hormone Cholecystokinin (CCK), which activates gut-brain neurologic signaling to mediate hunger. ARD-101 has demonstrated an ability to reduce hunger when used alone or in combination with currently available GLP-1 therapies. Based on promising clinical data from an ongoing ARD-101 trial, the FDA has granted the drug both Orphan Drug designation and Rare Pediatric Rare Disease designation in PWS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aardvark Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsBryan J., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aardvark Therapeutics's next move

See what Strategic adds

Aardvark Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.